Stockreport

Recursion Pharmaceuticals (NasdaqGS:RXRX) Jumps 12% Following US$500M Equity Offering [Yahoo! Finance]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF The company announced a significant follow-on equity offering of $500 million, which may have attracted investor attention. Additionally, Recursion's reported earnings f [Read more]